Spiro Medical
Neuromodulation for Severe Asthma
Irvine, United States · Founded 2023 · $67.0M raised
- Headquarters
- Irvine
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- spiromedical.com
- Total Funding
- $67.0M
- Last Round
- $67.0M Series AJan 2026
- Rounds
- 1
About
Spiro Medical develops the Spiro Neuromodulation System, a device-based therapy targeting severe chronic airway diseases such as asthma and COPD. The company is focused on transforming the treatment paradigm for patients who have exhausted conventional options.
Summary
Spiro Medical is a Healthcare company based in Irvine, United States, founded in 2023. It has raised $67.0M in total across 1 round, most recently a $67.0M Series A round in Jan 2026. Investors include Andera Partners, Sherpa Healthcare Partners and Omega Funds.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2026
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/spiro-medical"><img src="https://indexed.vc/api/badge/company/spiro-medical" alt="Spiro Medical on Indexed.vc" width="260" height="76" /></a>